203 related articles for article (PubMed ID: 33429293)
1. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
[TBL] [Abstract][Full Text] [Related]
2. Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
Pocha C; Knott A; Rector TS; Dieperink E
J Clin Psychiatry; 2014 Oct; 75(10):e1122-6. PubMed ID: 25373121
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients.
Chang CM; Hsieh MS; Yang TC; Hsieh VC; Chiang JH; Huang HH; How CK; Hu SY; Yen DH
Cancer Manag Res; 2017; 9():709-720. PubMed ID: 29238221
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
[TBL] [Abstract][Full Text] [Related]
5. SSRIs associated with decreased risk of hepatocellular carcinoma: A population-based case-control study.
Chan HL; Chiu WC; Chen VC; Huang KY; Wang TN; Lee Y; McIntyre RS; Hsu TC; Lee CT; Tzang BS
Psychooncology; 2018 Jan; 27(1):187-192. PubMed ID: 28666060
[TBL] [Abstract][Full Text] [Related]
6. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.
Lin WT; Liao YJ; Peng YC; Chang CH; Lin CH; Yeh HZ; Chang CS
World J Gastroenterol; 2017 May; 23(19):3513-3521. PubMed ID: 28596687
[TBL] [Abstract][Full Text] [Related]
7. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
[TBL] [Abstract][Full Text] [Related]
9. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
[TBL] [Abstract][Full Text] [Related]
10. Association between selective serotonin reuptake inhibitors and kidney cancer risk: A nationwide population-based cohort study.
Lee MJ; Huang CW; Chen YL; Yang YH; Chen VC
Int J Cancer; 2021 Mar; 148(6):1331-1337. PubMed ID: 32965039
[TBL] [Abstract][Full Text] [Related]
11. Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study.
Chou CC; Yen DJ; Lin YY; Wang YC; Lin CL; Kao CH
Mayo Clin Proc; 2017 Feb; 92(2):193-199. PubMed ID: 28160872
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
13. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
[TBL] [Abstract][Full Text] [Related]
14. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
Kwak N; Lee H; Kim BK; Yu YM; Kang HY
J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
[TBL] [Abstract][Full Text] [Related]
15. Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis.
Chen KH; Wang TY; Lee CP; Yang YH; McIntyre RS; Subramaniapillai M; Lee Y; Chen VC
Medicine (Baltimore); 2022 May; 101(18):e29202. PubMed ID: 35550469
[TBL] [Abstract][Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
17. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan.
Cheng YL; Hu HY; Lin XH; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
Medicine (Baltimore); 2015 Nov; 94(46):e2022. PubMed ID: 26579809
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
[TBL] [Abstract][Full Text] [Related]
20. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
